Immune Pharmaceuticals, Inc. (OTCMKTS:IMNPQ) Short Interest Down 99.8% in September

Immune Pharmaceuticals, Inc. (OTCMKTS:IMNPQ) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 100 shares, a decline of 99.8% from the September 15th total of 64,600 shares. Based on an average daily volume of 318,700 shares, the days-to-cover ratio is currently 0.0 days.

Immune Pharmaceuticals stock remained flat at $$0.00 during mid-day trading on Thursday. 30,054 shares of the company’s stock were exchanged, compared to its average volume of 1,927,076. Immune Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.18.

About Immune Pharmaceuticals

Immune Pharmaceuticals, Inc is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation.

Featured Story: What does it mean to hold a stock in street name?

Receive News & Ratings for Immune Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immune Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.